282
Views
7
CrossRef citations to date
0
Altmetric
Research Article

The Effect of Early Intensive Insulin Therapy on Body Fat Distribution and β-Cell Function in Newly Diagnosed Type 2 Diabetes

, , , , , & show all
Pages 160-167 | Published online: 03 Jan 2013

REFERENCES

  • Ilkova H, Glaser B, Tunçkale A, Bagriaçik N, Cerasi E. Induction of long-term glycaemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 1997;20:1353–1356.
  • Ryan EA, Imes S, Wallace C. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care 2004;27:1028–1032.
  • Li Y, Xu W, Liao Z, Induction of long-term glycaemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 2004;27:2597–2602.
  • Weng J, Li Y, Xu W, Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomized parallel-group trial. Lancet 2008;371:1753–1760.
  • Kissebach AH, Peiris AN. Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1989;5:83–109.
  • Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996;45:633–638.
  • Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994;74:761–811.
  • Klip A, Pâquet MR. Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 1990;13:228–243.
  • Kim TN, Yang SJ, Yoo HJ, Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond) 2009;33:885–892.
  • Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One 2010;5:e10805.
  • Ashford AJ, Pain VM. Insulin stimulation of growth in diabetic rats. Synthesis and degradation of ribosomes and total tissue protein in skeletal muscle and heart. J Biol Chem 1986;261:4066–4070.
  • Bennet WM, Connacher AA, Jung RT, Stehle P, Rennie MJ. Effects of insulin and amino acids on leg protein turnover in IDDM patients. Diabetes 1991;40:499–508.
  • Denne SC, Liechty EA, Liu YM, Brechtel G, Baron AD. Proteolysis in skeletal muscle and whole body in response to euglycemic hyperinsulinemia in normal adults. Am J Physiol 1991;261:E809–814.
  • Meek SE, Persson M, Ford GC, Nair KS. Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects. Diabetes 1998;47:1824–1835.
  • Chan JC, Malik V, Jia W, Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129–2140.
  • van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord 1993;17:187–196.
  • Heymsfield SB, Smith R, Aulet M, Appendicular skeletal muscle mass: measurement by dual photon absorptiometry. Am J Clin Nutr 1990;52:214–218.
  • Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D. Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr 2002;76:378–383.
  • Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889–896.
  • Seino Y, Ikeda M, Yawata M, Imura H. The insulinogenic index in secondary diabetes. Horm Metab Res 1975;7:107–115.
  • Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462–1470.
  • Juurinen L, Tiikkainen M, Häkkinen AM, Hakkarainen A, Yki-Järvinen H. Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 2007;292:E829–835.
  • Shah PK, Mudaliar S, Chang AR, Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes. Diabetes Obes Metab 2011;13:505–510.
  • Takei I, Takayama S, Yamauchi A, Effect of insulin therapy on body fat distribution in NIDDM patients with secondary sulfonylurea failure: a preliminary report. Eur J Clin Nutr 1998;52:153–154.
  • Yki-Järvinen H, Esko N, Eero H, Marja-Riitta T. Clinical benefits and mechanisms of sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. Am J Med 1988;84:185–192.
  • Kanauchi M, Tsujimoto N, Hashimoto T. Validation of simple indices to assess insulin sensitivity based on the oral glucose tolerance test in the Japanese population. Diabetes Res Clin Pract 2002;55:229–235.
  • Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 1995;27:435–438.
  • McPherron AC, Lee SJ. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 2002;109:595–601.
  • Etgen GJ Jr, Jensen J, Wilson CM, Exercise training reverses insulin resistance in muscle by enhanced recruitment of GLUT-4 to the cell surface. Am J Physiol 1997;272:E864–869.
  • Fiebig RG, Hollander JM, Ney D, Training down-regulates fatty acid synthase and body fat in obese Zucker rats. Med Sci Sports Exerc 2002;34:1106–1114.
  • Christ CY, Hunt D, Hancock J, Exercise training improves muscle insulin resistance but not insulin receptor signaling in obese Zucker rats. J Appl Physiol 2002;92:736–744.
  • Argilés JM, López-Soriano J, Almendro V, Busquets S, López-Soriano FJ. Cross-talk between skeletal muscle and adipose tissue: a link with obesity? Med Res Rev 2005;25:49–65.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.